NOT-DK-12-019: Notice of Intent to Publish NIDDK Funding Opportunity Announcement: Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)

Notice of Intent to Publish NIDDK Funding Opportunity Announcement: Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)

Notice Number: NOT-DK-12-019

Key Dates

Release Date: September 7, 2012
Estimated Publication Date of Announcement: October, 2012
First Estimated Application Due Date: February 21, 2013
Earliest Estimated Award Date: October, 2013
Earliest Estimated Start Date: October, 2013

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to reissue a Funding Opportunity Announcement (FOA), https://grants.nih.gov/grants/guide/pa-files/PAR-11-350.html .

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

The FOA is expected to be published in Fall of 2012 with an expected receipt date in February 21, 2013.

This FOA will utilize the DP3 activity code. Details of the planned FOA are provided below.

Research Initiative Details

An FOA is planned to continue to fund research in type 1 diabetes. It will be similar to PAR-11-350 and will encourage applications for ancillary studies using archived samples from selected type 1 diabetes clinical trials and studies. Ancillary studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Lisa M. Spain, Ph.D., Director
Immunobiology of Autoimmune Endocrine Diseases Program
Division of Diabetes, Endocrinology, and Metabolism
National Institute of Diabetes Digestive & Kidney Diseases (NIDDK)
Telephone: 301-451-9871
Email: [email protected]